|
NL270984A
(en)
|
1960-11-05 |
|
|
|
|
US3117160A
(en)
|
1961-07-27 |
1964-01-07 |
Pfizer & Co C |
Aralkylamines
|
|
US3198834A
(en)
|
1964-07-27 |
1965-08-03 |
Snc Science Union Et Compagnie |
Optical isomers of trifluoromethylated phenethylamines
|
|
GB1254332A
(en)
|
1969-02-27 |
1971-11-17 |
Science Union & Cie |
Amino acids and their derivatives and processes for preparing them
|
|
DE2143204C3
(en)
|
1971-08-28 |
1979-09-27 |
Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt |
N-fluoroalkyl-phenylisopropylamine derivatives and their salts, processes for their preparation and pharmaceuticals based on them
|
|
DE2150399A1
(en)
|
1971-10-09 |
1973-04-12 |
Hoechst Ag |
Alpha-oximinobenzyl cyanides - useful as pesticide inters
|
|
GB1413078A
(en)
|
1973-07-27 |
1975-11-05 |
Beecham Group Ltd |
Process for the production of plus-norfenfluramine and plus-fenfluramine and salts thereof
|
|
GB1413070A
(en)
|
1973-07-27 |
1975-11-05 |
Beecham Group Ltd |
Process for the production of - norfenfluramine and - fenfluramine and salts thereof
|
|
US4309445A
(en)
|
1980-06-16 |
1982-01-05 |
Massachusetts Institute Of Technology |
d-Fenfluramine for modifying feeding behavior
|
|
US4452815A
(en)
|
1980-06-16 |
1984-06-05 |
Massachusetts Institute Of Technology |
Method of utilizing d,l-fenfluramine for modifying feeding behavior
|
|
DE3717434C1
(en)
|
1987-05-23 |
1988-09-15 |
Degussa |
Process for the preparation of m-trifluoromethylphenylacetonitrile
|
|
US4857553A
(en)
|
1987-08-06 |
1989-08-15 |
A. H. Robins Company, Incorporated |
Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents
|
|
KR890003368A
(en)
|
1987-08-06 |
1989-04-14 |
원본미기재 |
How to treat nausea and vomiting with certain substituted phenylalkylamino (and amino acid) derivatives and other serotonin-lowering agents
|
|
HU204497B
(en)
|
1989-10-09 |
1992-01-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing phenfluramine
|
|
IT1238686B
(en)
|
1990-02-09 |
1993-09-01 |
Lab Mag Spa |
PROCEDURE FOR THE PREPARATION OF LEVO AND RIGHT FENFLURAMINA
|
|
FR2663539B1
(en)
|
1990-06-22 |
1994-10-07 |
Adir |
USE OF D-FENFLURAMINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF IMMUNE DEFICIENCIES IN THE AGED SUBJECT.
|
|
FR2684552B1
(en)
|
1991-12-06 |
1995-04-28 |
Adir |
USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
|
|
FR2685204B1
(en)
|
1991-12-19 |
1995-06-16 |
Palmer Research |
PHARMACEUTICAL COMPOSITIONS FOR THE TRANSCUTANEOUS ADMINISTRATION OF FENFLURAMINE.
|
|
US5985880A
(en)
|
1996-06-05 |
1999-11-16 |
Delta Pharmaceuticals |
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
|
|
DK0712387T3
(en)
|
1993-08-06 |
2000-05-29 |
Upjohn Co |
2-Aminoindanes as selective dopamine D3 ligands
|
|
US5834477A
(en)
|
1993-12-08 |
1998-11-10 |
The United States Of America As Represented By The Secretary Of The Army |
Opiate analgesic formulation with improved safety
|
|
US5412102A
(en)
|
1994-05-27 |
1995-05-02 |
Syntex (U.S.A.) Inc. |
Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
|
|
ES2157330T3
(en)
|
1994-06-03 |
2001-08-16 |
Thejmde Trust |
COMPOSITION INCLUDING ARIL-ALQUIL-AMINA SUBSTITUTED GOAL, THERAPEUTIC AND DIAGNOSTIC USES.
|
|
IT1298349B1
(en)
|
1996-05-29 |
2000-01-05 |
Alfa Chem Ital |
PROCESS FOR THE PRODUCTION OF 1 - (3-TRIFLUOROMETHYL) PHENYL-PROPAN- 2-ONE INTERMEDIATE IN THE SYNTHESIS OF PHENFLURAMINE
|
|
IT1292885B1
(en)
|
1997-04-28 |
1999-02-11 |
Alfa Chem Ital |
PROCESS FOR THE PRODUCTION OF (R) AND (S) - ALPHA-METHYL-3- (TRIFLUOROMETHYL) BENZENE-ETHANAMINE ISOMERS.
|
|
EP0920864A1
(en)
|
1997-12-03 |
1999-06-09 |
Pfizer Products Inc. |
Combination therapy including a specific beta-3 agonist and an anorectic agent
|
|
US20020098175A1
(en)
|
1998-06-16 |
2002-07-25 |
Zohoungbogbo Mathias C. |
Dietetic food composition and dietetic method using such composition
|
|
US6045501A
(en)
|
1998-08-28 |
2000-04-04 |
Celgene Corporation |
Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
|
|
WO2000038672A2
(en)
|
1998-12-23 |
2000-07-06 |
Orphan Medical, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US7124031B1
(en)
|
2000-05-11 |
2006-10-17 |
Medco Health Solutions, Inc. |
System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records
|
|
AU2001275095A1
(en)
|
2000-07-17 |
2002-01-30 |
Opt-E-Scrip, Inc. |
Single-patient drug trials used with accumulated database
|
|
US6315720B1
(en)
|
2000-10-23 |
2001-11-13 |
Celgene Corporation |
Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
|
|
JP2005503425A
(en)
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
Delivery of drug ester by the prescribed inhalation route
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
US7714020B2
(en)
|
2001-05-24 |
2010-05-11 |
Neuren Pharmaceuticals Limited |
Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
|
|
JP2004530436A
(en)
|
2001-06-22 |
2004-10-07 |
ユニべルシテ・カトリック・ドゥ・ルベン |
Hydrogel beads or capsules as artificial media for spawning insects and feeding endoparasitoids
|
|
AU2002324579B2
(en)
|
2001-07-31 |
2007-11-15 |
Wyeth |
Sucralose formulations to mask unpleasant tastes
|
|
AUPR732601A0
(en)
|
2001-08-28 |
2001-09-20 |
Polychip Pharmaceuticals Pty Ltd |
Methods for the synthesis of amines such as ephedrine and inter mediates
|
|
RU2317104C2
(en)
|
2001-09-24 |
2008-02-20 |
Импиэриэл Инноувейшнс Лимитид |
Method for modifying alimentary behavior and application of pyy or its agonist as a preparation for modifying alimentary behavior
|
|
BR0212985A
(en)
|
2001-09-24 |
2005-08-30 |
Imp College Innovations Ltd |
Use of pyy or an agonist in the preparation of medicaments for treating disorders associated with overweight
|
|
US6599901B1
(en)
|
2001-11-19 |
2003-07-29 |
Hoffman-La Roche Inc. |
Pyridone substituted benzothiazole derivatives
|
|
US7101572B2
(en)
|
2001-12-07 |
2006-09-05 |
Unilab Pharmatech, Ltd. |
Taste masked aqueous liquid pharmaceutical composition
|
|
WO2003077847A2
(en)
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Substituted amides
|
|
US7271266B2
(en)
|
2002-03-28 |
2007-09-18 |
Merck & Co., Inc. |
Substituted 2,3-diphenyl pyridines
|
|
US7668730B2
(en)
|
2002-12-17 |
2010-02-23 |
JPI Commercial, LLC. |
Sensitive drug distribution system and method
|
|
WO2005004865A1
(en)
|
2003-07-08 |
2005-01-20 |
Georg-August-Universität Göttingen |
Use of 5-ht4(a)-serotonin receptor agonists
|
|
GB0410266D0
(en)
|
2004-05-07 |
2004-06-09 |
Ketocytonyx Inc |
Treatment of apoptosis
|
|
US20050260610A1
(en)
|
2004-05-20 |
2005-11-24 |
Kurtz Richard E |
Method for diagnosing and prescribing a regimen of therapy for human health risk
|
|
US9820658B2
(en)
|
2006-06-30 |
2017-11-21 |
Bao Q. Tran |
Systems and methods for providing interoperability among healthcare devices
|
|
CN101374525A
(en)
|
2004-09-23 |
2009-02-25 |
莫茨药物股份两合公司 |
Memantine for the treatment of childhood behavioral disorders
|
|
CN100567252C
(en)
|
2004-10-11 |
2009-12-09 |
俞锋 |
Fenfluramine hydrochloride crude drug and tablet and preparation method thereof
|
|
US20090216132A1
(en)
|
2005-03-21 |
2009-08-27 |
Tuvi Orbach |
System for Continuous Blood Pressure Monitoring
|
|
RU2007148444A
(en)
|
2005-05-25 |
2009-06-27 |
Янссен Фармацевтика Н.В. (Be) |
PEDIATRIC TOPIRAMAT COMPOSITION
|
|
WO2006133199A2
(en)
|
2005-06-06 |
2006-12-14 |
University Of South Florida |
Treatment with sigma receptor agonists post-stroke
|
|
CA2612180A1
(en)
|
2005-06-16 |
2006-12-21 |
Bionomics Limited |
Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
|
|
GB0515090D0
(en)
|
2005-07-22 |
2005-08-31 |
Birmingham Res & Dev Ltd |
Novel epilepsy treatment
|
|
US9125900B2
(en)
|
2005-09-14 |
2015-09-08 |
University Of The Witwatersrand, Johannesburg |
Pharmaceutical composition
|
|
EP1926427A4
(en)
|
2005-09-19 |
2012-06-06 |
Biolert Ltd |
A device and method for detecting an epileptic event
|
|
EP3703058A1
(en)
|
2005-11-29 |
2020-09-02 |
Children's Hospital Medical Center |
A method of selecting a medication for a patient
|
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
WO2007079181A2
(en)
|
2005-12-28 |
2007-07-12 |
Neurovista Corporation |
Methods and systems for recommending an action to a patient for managing epilepsy and other neurological disorders
|
|
JP2009525977A
(en)
|
2006-02-06 |
2009-07-16 |
ノバルティス アクチエンゲゼルシャフト |
Combination of organic compounds
|
|
DE102006030113B4
(en)
|
2006-06-28 |
2009-02-12 |
Chemische Fabrik Budenheim Kg |
Graphite-free high-temperature lubricant
|
|
WO2008021954A2
(en)
|
2006-08-09 |
2008-02-21 |
Biogen Idec Ma Inc. |
Method for distribution of a drug
|
|
CA2660431C
(en)
|
2006-08-31 |
2015-03-17 |
The Governors Of The University Of Alberta |
Method of inhibition of respiratory depression using positive allosteric ampa receptor modulators
|
|
US20080183498A1
(en)
|
2007-01-31 |
2008-07-31 |
Quintiles Transnational Corp., Inc. |
Methods and systems for site startup
|
|
EP3135282A1
(en)
|
2007-02-08 |
2017-03-01 |
Biogen MA Inc. |
Neuroprotection in demyelinating diseases
|
|
EP2125799A1
(en)
|
2007-02-28 |
2009-12-02 |
Smithkline Beecham Corporation |
Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
|
|
GB2456183A
(en)
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
|
EP2240022B1
(en)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Bilayered tablets comprising oxycodone and promethazine
|
|
MX2011001384A
(en)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Compositions and methods for treating psychiatric disorders.
|
|
WO2010020585A1
(en)
*
|
2008-08-18 |
2010-02-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serotonin reuptake inhibitors for the treatment of rett syndrome
|
|
ES2513394T3
(en)
|
2008-09-05 |
2014-10-27 |
Grünenthal GmbH |
Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2-methylpropyl) phenol and an antiepileptic
|
|
US8386274B1
(en)
|
2008-09-17 |
2013-02-26 |
Mckesson Financial Holdings Limited |
Systems and methods for a prescription safety network utilizing eligibility verification transactions
|
|
CA2737391A1
(en)
|
2008-10-09 |
2010-04-15 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
Liquid pharmaceutical formulation containing paracetamol
|
|
WO2010042780A2
(en)
|
2008-10-10 |
2010-04-15 |
The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of Walter Reed Army Institute Of Research |
Methods and compositions for treating status epilepticus and seizures causing status epilepticus
|
|
TWI503101B
(en)
|
2008-12-15 |
2015-10-11 |
Proteus Digital Health Inc |
Body-associated receiver and method
|
|
EP2406765A4
(en)
|
2009-03-09 |
2014-12-31 |
Celgene Corp |
Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
|
|
EP2419400A1
(en)
|
2009-04-15 |
2012-02-22 |
Research Triangle Institute |
Monoamine reuptake inhibitors
|
|
US20100324936A1
(en)
|
2009-04-22 |
2010-12-23 |
Suresh-Kumar Venkata Vishnubhatla |
Pharmacy management and administration with bedside real-time medical event data collection
|
|
US9453027B2
(en)
|
2009-07-27 |
2016-09-27 |
Daljit Singh Dhanoa |
Deuterium-enriched pyridinonecarboxamides and derivatives
|
|
TW201127375A
(en)
|
2010-01-08 |
2011-08-16 |
Eurand Inc |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
|
CN103025301B
(en)
|
2010-03-09 |
2016-11-09 |
破赛普提医药有限公司 |
Medication Validation and Dispensing
|
|
WO2011119227A2
(en)
|
2010-03-25 |
2011-09-29 |
Columbia Northwest Pharmaceuticals, Llc |
Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
|
|
JP2011221623A
(en)
|
2010-04-06 |
2011-11-04 |
Kakimori Suri |
Home medical care support system and method
|
|
AU2011255276B2
(en)
|
2010-05-21 |
2016-09-22 |
Research Triangle Institute |
Phenylmorpholines and analogues thereof
|
|
EP2399513B1
(en)
|
2010-06-23 |
2017-01-04 |
Qatar University Qstp-B |
System for non-invasive automated monitoring, detection, analysis, characterisation, prediction or prevention of seizures and movement disorder symptoms
|
|
WO2012015712A1
(en)
|
2010-07-30 |
2012-02-02 |
Schering Corporation |
Inhibition of cyp3a drug metabolism
|
|
CA2808912C
(en)
|
2010-09-01 |
2019-09-17 |
Zezhi Jesse Shao |
Modified-release dosage forms of 5-ht2c agonists useful for weight management
|
|
US20120270848A1
(en)
|
2010-10-22 |
2012-10-25 |
Galleon Pharmaceuticals, Inc. |
Novel Compositions and Therapeutic Methods Using Same
|
|
CN103189055A
(en)
|
2010-10-26 |
2013-07-03 |
雅来制药有限责任公司 |
Formulations and methods for attenuating respiratory depression induced by opioid overdose
|
|
RU103209U1
(en)
|
2010-10-29 |
2011-03-27 |
Общество С Ограниченной Ответственностью "Правовое Сопровождение Бизнеса" |
CLINICAL INFORMATION SYSTEM
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
US10183008B2
(en)
|
2011-02-09 |
2019-01-22 |
University Of South Carolina |
Treatment of prolonged status epilepticus
|
|
JP5693325B2
(en)
|
2011-03-29 |
2015-04-01 |
小林クリエイト株式会社 |
Medical examination result output system and medical examination result output program
|
|
TWI542596B
(en)
|
2011-05-09 |
2016-07-21 |
健生藥品公司 |
(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxyl L-proline and citric acid cocrystals of methyl)tetrahydro-2H-piperan-3,4,5-triol
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
US10092750B2
(en)
|
2011-11-11 |
2018-10-09 |
Neuroenabling Technologies, Inc. |
Transcutaneous neuromodulation system and methods of using same
|
|
WO2013096878A1
(en)
|
2011-12-22 |
2013-06-27 |
University Of Idaho |
Garcinia buchananii baker compounds, compositions and related methods
|
|
WO2013112363A1
(en)
|
2012-01-27 |
2013-08-01 |
Catalyst Pharmaceutical Partners |
Method of treating tourette's disorder with gaba-aminotransferase inactivators
|
|
WO2013122897A1
(en)
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
US20130218586A1
(en)
|
2012-02-21 |
2013-08-22 |
Frederic J. Huser |
Methods and elements for identifying the appropriate patient populations who can safely use prescription chronic care drugs that are switched to an over-the-counter regulatory status
|
|
JP6075973B2
(en)
|
2012-06-04 |
2017-02-08 |
富士通株式会社 |
HEALTH STATE JUDGING DEVICE AND ITS OPERATION METHOD
|
|
WO2014071134A1
(en)
|
2012-11-05 |
2014-05-08 |
Emory University |
7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
|
|
EP2920155A2
(en)
|
2012-11-15 |
2015-09-23 |
Galleon Pharmaceuticals, Inc. |
Novel orally bioavailable breathing control modulating compounds, and methods of using same
|
|
WO2014106825A2
(en)
|
2013-01-06 |
2014-07-10 |
Jonathan Rabinowitz |
Methods and devices for identifying improper medical reporting
|
|
US9549909B2
(en)
|
2013-05-03 |
2017-01-24 |
The Katholieke Universiteit Leuven |
Method for the treatment of dravet syndrome
|
|
HUE049302T2
(en)
|
2013-07-25 |
2020-09-28 |
Neuren Pharmaceuticals Ltd |
Neuroprotective bicyclic compounds and their use in the treatment of autism spectrum disorders and neurodevelopmental disorders
|
|
HRP20201302T1
(en)
|
2013-08-19 |
2021-02-05 |
The Regents Of The University Of California |
Compounds and methods for treating an epileptic disorder
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
WO2015077057A1
(en)
|
2013-11-20 |
2015-05-28 |
Texas Southern University |
Methionine aminopeptidase inhibitors for treating infectious diseases
|
|
CN103886415A
(en)
|
2014-03-25 |
2014-06-25 |
北京蝶禾谊安信息技术有限公司 |
Method and device for managing drugs
|
|
CN106461677B
(en)
|
2014-04-22 |
2018-09-11 |
国立大学法人东北大学 |
The inspection method of pulmonary hypertension disease
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
US10849518B2
(en)
|
2014-06-30 |
2020-12-01 |
University Of Cincinnati |
Non-invasive detection of spreading depolarization using scalp electroencephalography
|
|
CA2962367A1
(en)
|
2014-09-29 |
2016-04-07 |
Zogenix International Limited |
Control system for control of distribution of medication
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
IL252848B2
(en)
|
2015-02-06 |
2024-07-01 |
Marinus Pharmaceuticals Inc |
Intravenous ganaxolone formulations and their use in treating status epilepticus and other seizure disorders
|
|
EP3632434A1
(en)
|
2015-02-25 |
2020-04-08 |
The Regents of the University of California |
The 5ht agonist clemizole for use in treating disorders
|
|
US10292996B2
(en)
|
2015-03-26 |
2019-05-21 |
The Trustees Of Columbia University In The City Of New York |
Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion syndrome
|
|
CN104800168A
(en)
|
2015-04-08 |
2015-07-29 |
石家庄四药有限公司 |
Stiripentol dry suspension and preparation method thereof
|
|
JP6668045B2
(en)
|
2015-05-15 |
2020-03-18 |
ゾゲニクス インターナショナル リミテッド |
Selective 5-HT receptor agonists and antagonists for treating Dravet syndrome
|
|
ES2808148T3
(en)
|
2015-06-17 |
2021-02-25 |
Univ Columbia |
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide clusters including mitochondrial DNA depletion syndromes
|
|
NO346258B1
(en)
|
2015-06-30 |
2022-05-16 |
Neurad Ltd |
Novel breathing control modulating compounds, and methods of making and using same
|
|
ES2925951T3
(en)
|
2015-07-22 |
2022-10-20 |
John Hsu |
Composition comprising a therapeutic agent and a respiratory stimulant and methods for its use
|
|
EP4397372A3
(en)
|
2015-08-24 |
2024-09-11 |
Zogenix International Limited |
Methods of treating lennox-gastaut syndrome using fenfluramine
|
|
US20220193082A1
(en)
|
2015-09-14 |
2022-06-23 |
Zogenix International Limited |
Combination treatment of specific forms of epilepsy
|
|
US20170071949A1
(en)
|
2015-09-14 |
2017-03-16 |
Zogenix International Limited |
Combination treatment of specific forms of epilepsy
|
|
EP3170807B1
(en)
|
2015-11-23 |
2019-12-11 |
Frau Pharma S.r.l. |
New method for synthesis of fenfluramine
|
|
WO2017112701A1
(en)
|
2015-12-22 |
2017-06-29 |
Zogenix International Limited |
Metabolism resistant fenfluramine analogs and methods of using the same
|
|
SG10202005916QA
(en)
|
2015-12-22 |
2020-07-29 |
Zogenix International Ltd |
Fenfluramine compositions and methods of preparing the same
|
|
JP6753418B2
(en)
|
2016-01-14 |
2020-09-09 |
Ａｇｃ株式会社 |
Fluororesin-containing solution, method for producing fluororesin-containing solution, paint composition and painted article
|
|
EP3437644B1
(en)
|
2016-03-28 |
2021-06-30 |
Takeda Pharmaceutical Company Limited |
Compounds for use in the treatment of pulmonary hypertension
|
|
SG11201900975XA
(en)
|
2016-08-24 |
2019-03-28 |
Zogenix International Ltd |
Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
|
|
US20190083425A1
(en)
|
2016-08-24 |
2019-03-21 |
Zogenix International Limited |
Formulation for inhibiting formation of 5-ht2b agonists and methods of using same
|
|
US20180092864A1
(en)
|
2016-09-30 |
2018-04-05 |
Zogenix International Limited |
Compositions and methods for treating seizure disorders
|
|
CA3051699A1
(en)
|
2017-02-08 |
2018-08-16 |
Ovid Therapeutics Inc. |
Methods of treating seizure disorders and prader-willi syndrome
|
|
MX2019013279A
(en)
*
|
2017-05-09 |
2020-01-15 |
Zogenix International Ltd |
Methods of treating doose syndrome using fenfluramine.
|
|
US20190091179A1
(en)
|
2017-09-26 |
2019-03-28 |
Zogenix International Limited |
Congnitive function with fenfluramine
|
|
WO2019067413A1
(en)
|
2017-09-26 |
2019-04-04 |
Zogenix International Limited |
Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations
|
|
US10682317B2
(en)
|
2017-09-26 |
2020-06-16 |
Zogenix International Limited |
Ketogenic diet compatible fenfluramine formulation
|
|
US20190125697A1
(en)
|
2017-09-26 |
2019-05-02 |
Zogenix International Limited |
Method of reduction in convulsive seizure frequency
|
|
US20190247333A1
(en)
|
2017-09-26 |
2019-08-15 |
Zogenix International Limited |
Method of reduction in convulsive seizure frequency
|
|
GB201715919D0
(en)
|
2017-09-29 |
2017-11-15 |
Gw Res Ltd |
use of cannabinoids in the treatment of epilepsy
|
|
US11352882B2
(en)
|
2018-03-12 |
2022-06-07 |
Cameron International Corporation |
Plug assembly for a mineral extraction system
|
|
MX2020010994A
(en)
|
2018-04-18 |
2021-01-08 |
Univ Columbia |
GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED COMBINATIONS OF NUCLEOTIDES INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES.
|
|
US11571397B2
(en)
|
2018-05-11 |
2023-02-07 |
Zogenix International Limited |
Compositions and methods for treating seizure-induced sudden death
|
|
EP3806835A1
(en)
|
2018-06-14 |
2021-04-21 |
Zogenix International Limited |
Compositions and methods for treating respiratory depression with fenfluramine
|
|
JP2021530481A
(en)
|
2018-07-10 |
2021-11-11 |
ゾゲニクス インターナショナル リミテッド |
Fenfluramine for use in treating epilepsy or epileptic encephalopathy in patients without pulmonary hypertension
|
|
JP2021530541A
(en)
*
|
2018-07-27 |
2021-11-11 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. |
How to treat epilepsy
|
|
EP3883555A1
(en)
|
2018-11-19 |
2021-09-29 |
Zogenix International Limited |
Methods of treating rett syndrome using fenfluramine
|
|
US20210401776A1
(en)
|
2018-11-30 |
2021-12-30 |
Zogenix International Limited |
Method of treating refractory epilepsy syndromes using fenfluramine enantiomers
|
|
JP2022521446A
(en)
|
2019-02-25 |
2022-04-07 |
ゾゲニクス インターナショナル リミテッド |
Formulations to improve seizure control
|
|
US20210299064A1
(en)
|
2020-02-05 |
2021-09-30 |
Zogenix International Limited |
Method of treating patients with lennox-gastaut syndrome
|
|
US11612574B2
(en)
|
2020-07-17 |
2023-03-28 |
Zogenix International Limited |
Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
|
US20220096514A1
(en)
|
2020-09-29 |
2022-03-31 |
Zogenix International Limited |
Methods of treating thymidine kinase 2 deficiency by administering deoxycytidine and deoxythymidine
|
|
US11949918B2
(en)
|
2021-04-15 |
2024-04-02 |
Lemon Inc. |
Unified neural network in-loop filter signaling
|
|
WO2023034115A1
(en)
|
2021-09-01 |
2023-03-09 |
Zogenix International Limited |
Fenfluramine for treatment of demyelinating diseases and conditions
|
|
US20230165810A1
(en)
|
2021-12-01 |
2023-06-01 |
Zogenix International Limited |
Fenfluramine for treatment of conditions associated with spreading depolarization
|